SCHEMBL2287477

SCHEMBL2287477

Cc1cccc(C)c1OCc1cc(Oc2ccc(C(C)(C)C)cc2C(C)(C)C)ccc1C=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 2/20 0.35
MAPT P10636 6/20 0.33
ALDH1A1 P00352 4/20 0.33
SCN2A Q99250 2/20 0.33
POLB P06746 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 2/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
PLA2G1B P04054 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ATG4B Q9Y4P1 1/20 0.32
KDM4E B2RXH2 1/20 0.32
USP2 O75604 1/20 0.31
HPGD P15428 1/20 0.31
CXCR5 P32302 1/20 0.31
TUBB1 Q9H4B7 1/20 0.31
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2290701 0.84 MRGPRX4 (0.38) MRGPRX4MAPTALDH1A1SCN2APOLB
SCHEMBL2295515 0.84 MRGPRX4 (0.35) MRGPRX4MAPTALDH1A1SCN2APOLB
SCHEMBL2288078 0.81 FFAR1 (0.42) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL2295498 0.81 NPSR1 (0.36) MRGPRX4MAPTALDH1A1POLBMEN1
SCHEMBL1201118 0.78 CDK4 (0.41) ALDH1A1KMT2ASMN1; SMN2TDP1L3MBTL1
SCHEMBL2294471 0.78 ALDH1A1 (0.42) MAPTALDH1A1KMT2ASMN1; SMN2NPSR1
SCHEMBL2287699 0.77 ALDH1A1 (0.43) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL2293617 0.76 TRIM24 (0.49) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL1199640 0.76 MAPT (0.37) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL2292794 0.76 SCN8A (0.39) MAPTALDH1A1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2149545-B1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2016-10-05 EP disclosed
US-7994367-B2 Method for producing benzaldehyde compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-09 US disclosed
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-19 US disclosed
EP-2149545-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND NQO1, C9, TRPA1 MRGPRX4 282/4885MAPT 3284/4885ALDH1A1 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.